Sarcopenia Among Patients With Metabolic Dysfunction-associated Steatotic Liver Disease

Risk Factors and Prediction Model for Liver-Related Outcomes in Elderly Patients With Steatotic Liver Disease

NCT07537829 ·Status: COMPLETED

Role of ALBI Score and Sarcopenia As Prognostic Predictors Among Hospitalized Cirrhotic Patients with Hepatic Encephalopathy

NCT06679868 ·Status: NOT_YET_RECRUITING

A Community-based Prospective Cohort Study on Metabolic Dysfunction-Associated Fatty Liver Disease in Older Adults: From Metabolic Trajectories to Extrahepatic Outcomes

NCT07241195 ·Status: RECRUITING

A Cross Sectional Study for Determining Prevalence of Sarcopenia and Myosteatosis in Cirrhotic Patients and to Study the Association Between Imaging and Clinical Parameters

NCT05157308 ·Status: UNKNOWN

Ultrasound Assessment of Sarcopenia in Patients With Chronic Liver Disease: the SARCOLIVER Study

NCT06101758 ·Status: RECRUITING ·Phase: NA

MAsS Scan as a Predictor of Morbidity and Mortality in Patients With Liver Disease

NCT05264051 ·Status: RECRUITING

Relevance of Sarcopenia in Advanced Liver Disease

NCT05502198 ·Status: RECRUITING

Prevalence of Obesity in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

NCT07451366 ·Status: NOT_YET_RECRUITING

Muscles in Liver Diseases

NCT04758793 ·Status: NOT_YET_RECRUITING ·Phase: NA

Precision Medicine to Predict the Trajectory of Liver Cirrhosis: Prospective Cohort Study

NCT05899309 ·Status: UNKNOWN

Protocol for Muscle Attenuation Cut-offs in Cirrhosis

NCT06593015 ·Status: COMPLETED

Characterization of the Nutritional Status in the Patient With Liver Cirrhosis

NCT04073693 ·Status: COMPLETED ·Phase: NA

Effect of Sarcopenia on HCC After Lenvatinib and Anti-PD-1 Treatment

NCT05443230 ·Status: UNKNOWN

Metabolic Syndrome and Long-term Survival Following Liver Resection

NCT05568576 ·Status: COMPLETED

The Association Between Skeletal Muscle Mass and Severity of Polycystic Liver Disease and Polycystic Kidney Disease

NCT05215964 ·Status: UNKNOWN

Impact of Muscle Insulin Resistance on the Pathogenesis of Non Alcoholic Steatohepatitis

NCT01324414 ·Status: COMPLETED

Serum Ferritin as a Non-invasive Marker in Prediction of Hepatic Fibrosis Among NAFLD Patients

NCT03250572 ·Status: COMPLETED

Sarcopenia and Systemic Therapy in HCC

NCT06805552 ·Status: RECRUITING

Fatty Liver Disease Collaborative Research in China

NCT02391168 ·Status: UNKNOWN

Study on Risk Factors and Prognosis of MASLD

NCT07433205 ·Status: COMPLETED

Relation Between NAFLD and BM DENSITY

NCT06038253 ·Status: NOT_YET_RECRUITING

Skeletal Muscle Parameters of Liver Cirrhosis in Non-invasive Imaging and Outcome

NCT03584204 ·Status: RECRUITING

The Effect of Aerobic and Resistant Exercise Training in Patients With Non-Alcoholic Steatohepatitis

NCT05065593 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Assessment of Nonalcoholic Fatty Liver Disease in Diabetic and Prediabetic Patients Using Noninvasive Methods.

NCT04553796 ·Status: UNKNOWN

Validity of Laboratory Biomarkers in Diagnosis of Nonalcoholic Fatty Liver Disease (NAFLD) and It's Consequences

NCT06908122 ·Status: NOT_YET_RECRUITING